Guía de Práctica Clínica sobre Trastorno Bipolar - GuíaSalud

33. Morselli PL, Elgie R y Cesana BM. GAMIAN-Europe/BEAM survey II: cross-national
analysis of unemployment, family history, treatment satisfaction and impact of the
bipolar disorder on life style. Bipolar Disord, 2004; 6 (6): 487-497.
34. Simpson SG y Jamison KR. The risk of suicide in patients with bipolar disorders. J Clin
Psychiatry, 1999; 60 Suppl 2: 53-56; discussion 75-56, 113-116.
35. Angst J. Bipolar disorder--a seriously underestimated health burden. Eur Arch Psychiatry
Clin Neurosci, 2004; 254 (2): 59-60.
36. Woods SW. The economic burden of bipolar disease. J Clin Psychiatry, 2000; 61 Supp
13: 38-41.
37. Vieta E, Pacchiarotti I, Scott J, Sanchez-Moreno J, Di Marzo S y Colom F. Evidencebased
research on the efficacy of psychologic interventions in bipolar disorders: a critical
review. Current psychiatry reports, 2005; 7 (6): 449-455.
38. De Dios C, Ezquiaga E, Garcia A, Soler B y Vieta E. Time spent with symptoms in a
cohort of bipolar disorder outpatients in Spain: a prospective, 18-month follow-up study.
J Affect Disord, 2010; 125 (74-81).
39. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA
y Keller MB. The long-term natural history of the weekly symptomatic status of bipolar I
disorder. Arch Gen Psychiatry, 2002; 59 (6): 530-537.
40. Kupka RW, Altshuler LL, Nolen WA, Suppes T, Luckenbaugh DA, Leverich GS, Frye
MA, Keck PE, Jr., McElroy SL, Grunze H y Post RM. Three times more days depressed
than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord, 2007;
9 (5): 531-535.
41. Angst J, Felder W y Lohmeyer B. Schizoaffective disorders. Results of a genetic
investigation, I. J Affect Disord, 1979; 1 (2): 139-153.
42. Winokur G y Kadrmas A. A polyepisodic course in bipolar illness: possible clinical
relationships. Compr Psychiatry, 1989; 30 (2): 121-127.
43. Gitlin MJ, Swendsen J, Heller TL y Hammen C. Relapse and impairment in bipolar
disorder. Am J Psychiatry, 1995; 152 (11): 1635-1640.
44. Chengappa KN, Baker RW, Shao L, Yatham LN, Tohen M, Gershon S y Kupfer D. Rates
of response, euthymia and remission in two placebo-controlled olanzapine trials for
bipolar mania. Bipolar Disorders,, 2003; 5: 1-5.
45. Perlick DA, Hohenstein JM, Clarkin JF, Kaczynski R y Rosenheck RA. Use of mental
health and primary care services by caregivers of patients with bipolar disorder: a
preliminary study. Bipolar Disord, 2005; 7 (2): 126-135.
46. Suppes T, Leverich GS, Keck PE, Nolen WA, Denicoff KD, Altshuler LL, McElroy SL,
Rush AJ, Kupka R, Frye MA, Bickel M y Post RM. The Stanley Foundation Bipolar
Treatment Outcome Network. II. Demographics and illness characteristics of the first 261
patients. J Affect Disord, 2001; 67 (1-3): 45-59.
47. Swann AC, Petty F, Bowden CL, Dilsaver SC, Calabrese JR y Morris DD. Mania:
gender, transmitter function, and response to treatment. Psychiatry research, 1999; 88:
55-61.
48. Sanchez-Moreno J, Martinez-Aran A, Tabares-Seisdedos R, Torrent C, Vieta E y Ayuso-
Mateos JL. Functioning and disability in bipolar disorder: an extensive review.
Psychother Psychosom, 2009; 78 (5): 285-297.
49. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C y Murray CJ. Global burden of
depressive disorders in the year 2000. Br J Psychiatry, 2004; 184: 386-392.
50. Keck PE, Jr., McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, Bourne ML
y Haggard P. 12-month outcome of patients with bipolar disorder following
hospitalization for a manic or mixed episode. Am J Psychiatry, 1998; 155 (5): 646-652.
51. Pope M, Dudley R y Scott J. Determinants of social functioning in bipolar disorder.
Bipolar Disord, 2007; 9 (1-2): 38-44.
402 SANIDAD